advancing NEUROPSYCHIATRY COMPANIES
Dragonfly 44 is an unusual galaxy, composed mostly of dark matter—a mysterious, invisible substance that still shapes its structure. Inspired by this concept, Dragonfly 44 Capital, founded in 2023 and based in New York City, focuses on helping the companies who are deciphering the mysteries of the human mind.
The firm provides comprehensive financial and strategic services, including mergers and acquisitions support, fundraising guidance, and tailored consulting. Backed by a team with deep expertise in these fields, Dragonfly 44 Capital helps clients navigate complex challenges, identify new opportunities, and achieve sustainable growth.
Our Expertise
With a deep knowledge of neuropsychiatry, mental healthcare, psychedelics, longevity, and wellness, Dragonfly 44 Capital is committed to delivering comprehensive investment consultation that’s tailored to help companies navigate the complexities of these burgeoning spaces and unlock their full potential.
We position our clients for success during key business decisions across M&A, strategic financings, business development initiatives, and growth investments to help them to execute with confidence even through the most turbulent market conditions.
